-
SCOR to postpone its Investor Day
Источник: Nasdaq GlobeNewswire / 11 мар 2022 10:16:08 America/New_York
Press Release
March 11, 2022 - N° 6SCOR to postpone its Investor Day
In light of the geopolitical situation and the humanitarian and global impacts of the war in Ukraine, SCOR has decided to postpone its Investor Day, initially scheduled for March 29, 2022.
The Group is closely monitoring the impact of Russia’s invasion of Ukraine on its activity. The potential macro-economic consequences, from energy prices and inflation to interest rates and economic growth, are wide-ranging.
SCOR’s Investor Day will be rescheduled to take place by the end of July 2022. A date will be announced as the situation becomes clearer.
SCOR will strictly comply with all applicable sanctions. SCOR is ensuring that all its employees and their families in the region are safe.
Overall, SCOR’s exposure to Russia and Ukraine is limited. The direct consequences of these events are expected to be limited, and will not impact the Group’s fundamentals.
The Group is fully mobilized to pursue the execution of its strategic plan “Quantum Leap”, and to write the next chapters of SCOR’s story.
*
* *
Contact details
Media Relations
Nathalie Mikaeloff
media@scor.comInvestor Relations
Yves Cormier
ycormier@scor.comwww.scor.com
LinkedIn: SCOR | Twitter: @SCOR_SESCOR, a Global Tier 1 Reinsurer
SCOR, the world’s fourth largest reinsurer, offers its clients a diversified and innovative range of solutions and services to control and manage risk. Applying “The Art & Science of Risk”, SCOR uses its industry-recognized expertise and cutting-edge financial solutions to serve its clients and contribute to the welfare and resilience of society.
SCOR offers its clients an optimal level of security with its AA- rating or equivalent from S&P, Moody’s, Fitch and AM Best. The Group generated premiums of more than EUR 17.5 billion in 2021, and serves clients in more than 160 countries from its 36 offices worldwide.
For more information, visit: www.scor.com.
Attachment